We improve the immunogenicity of vaccine by combining the traditionally used safe soluble protein technology and modern nanoparticle technology.
A powerful platform to develop universal vaccine
We employ this cutting edge technology to discover therapeutic antibodies from immunized animals or human samples. These antibodies expose the vulnerable sites of virus, which in return to help us design effective vaccines.
Copyright © 2020 ReVacc Biotech - All Rights Reserved.